• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
XIAO Ting, WANG Chen, TIAN Ye, ZHANG Xia, LIU Ying, MA Bufang, LIU Shuyu, YAO Shangchen, FENG Yanchun. Establishment of national reference standard of tazobactam impurity A[J]. Journal of China Pharmaceutical University, 2021, 52(1): 60-65. DOI: 10.11665/j.issn.1000-5048.20210108
Citation: XIAO Ting, WANG Chen, TIAN Ye, ZHANG Xia, LIU Ying, MA Bufang, LIU Shuyu, YAO Shangchen, FENG Yanchun. Establishment of national reference standard of tazobactam impurity A[J]. Journal of China Pharmaceutical University, 2021, 52(1): 60-65. DOI: 10.11665/j.issn.1000-5048.20210108

Establishment of national reference standard of tazobactam impurity A

Funds: This study was supported by National Science and Technology Support Program(2015BAK45B01)
More Information
  • Received Date: September 28, 2020
  • Revised Date: December 09, 2020
  • To improve the standard of quality control of tazobactam and its preparations in China, national reference standard of tazobactam impurity A was developed. After tazobactam impurity A was synthesized, its structure was validated by infrared (IR), mass spectrometry (MS) and nuclear magnetic resonance (NMR), and its content uniformity and short-term stability were measured and investigated. Then, water content and residue on ignition of impurity A were determined, and its purity was determined using high performance liquid chromatography (HPLC) with 10 mmol/L ammonium acetate solution-acetonitrile (98∶2) as the mobile phase. Mass balance method was used to determine the content of the first batch of tazobactam impurity A national standard substance. Meanwhile, nuclear magnetic quantitative method was used to calculate the content, which was mutually verified with the mass balance method. The developed reference material of tazobactam impurity A is consistent with the maximum degradation impurity in tazobactam system applicability solution and the reference material of tazobactam related substance A contained in USP41. Within the 95% confidence range, the ratio of inter- and intra-bottle variance of impurity A after separation was 0.61 (< F0.05(11,12)), proving that the uniformity was satisfying. The contents of organic impurity, water content and inorganic impurity in impurity A were 0.90%, 1.24% and 0.25%, respectively. The content of impurity A was determined to be 97.6% by mass balance method, which was basically consistent with the result of nuclear magnetic quantitative method (97.1%). Under the condition of 25 °C, the area normalized purity of impurity A was 99.1% at 0, 3, 5 and 10 days, proving that the sample was stable at room temperature for 10 days. Finally the first batch of national standard substance of tazobactam impurity A was established successfully.
  • [1]
    . Beijing: China Medical Science and Technology Press, 2020: 34-35.
    [2]
    Singh DK, Sahu A, Kumar S, et al. Critical review on establishment and availability of impurity and degradation product reference standards, challenges faced by the users, recent developments, and trends[J]. Trac Trends Anal Chem, 2018, 101: 85-107.
    [3]
    Rose U. In situ degradation: a new concept for system suitability tests in monographs of the European Pharmacopoeia[J]. J Pharm Biomed Anal, 1998, 18(1/2): 1-14.
    [4]
    Zhang WQ, Hu CQ. Theory of selectivity of RP-LC C18 column and its application[J]. Acta Pharm Sin (药学学报), 2010, 45(5): 555-559.
    [5]
    Li W, Zhang WQ, Li Q, et al. Development and application of reference materials containing mixed degradation products of amoxicillin and ampicillin[J]. Acta Pharm Sin (药学学报),2014, 49 (9): 1310-1314.
    [6]
    Bai GY, Ma GQ, Hou ML, et al. Development of β-lactamase inhibitors[J]. Chem Ind Eng (化学工业与工程),2001, 18(6): 395-400.
    [7]
    Feng YC, Wang C, Tian Y, et al. Establishment of national reference standard of fluconazole impurity H[J]. Chin Pharm J (中国药学杂志),2018, 53(17): 1516-1522.
    [8]
    Lee VJ, Lenhard R, Cesark FF, et al. An efficient degradation of tazobactam, a beta-lactamase inhibitor, to metabolite M-1[J]. Synth Commun, 1994, 24(11): 1597-1601.
    [9]
    Marunaka T, Maniwa M, Matsushima E, et al. High-performance liquid chromatographic determination of a new beta-lactamase inhibitor and its metabolite in combination therapy with piperacillin in biological materials[J]. J Chromatogr, 1988, 431(1): 87-101.
    [10]
    Marunaka T, Matsushima E, Minami Y, et al. Degradation of beta-lactamase inhibitor, (2S, 3R, 5S)-3-methyl-7-oxo-3-(1H-1, 2, 3-triazol-1-yl-methyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4, 4-dioxide (YTR-830H), in aqueous solutions and alkaline methanol solution: pathway and structural elucidation of products[J]. Chem Pharm Bull (Tokyo), 1988, 36(11): 4478-4487.
    [11]
    Liu Y, Hu CQ. Fundamental research and application of the knowledge base for residual solvent determination in pharmaceuticals[J]. Chin J Pharm Anal (药物分析杂志),2007, 27(12): 1938-1943.
  • Related Articles

    [1]HOU Yurong, FAN Qingfeng, SHI Sunliang, YUAN Yaozuo, ZHANG Mei. Determination of the content of sisomicin sulfate and sodium chloride injection by RP-HPLC[J]. Journal of China Pharmaceutical University, 2018, 49(6): 695-698. DOI: 10.11665/j.issn.1000-5048.20180609
    [2]YAN Zhengyu, SHU Juan, YU Yan, ZHANG Zhengwei, TANG Lu, CHEN Jianqiu. Preparation and application of carbon dots in chloramphenicol determination[J]. Journal of China Pharmaceutical University, 2015, 46(3): 322-327. DOI: 10.11665/j.issn.1000-5048.20150310
    [3]ZHONG Wen-ying, HUANG Bin, CHEN Lin, SHU Chang. Fluorescence resonance energy transfer quenching for determination of vitamin B2[J]. Journal of China Pharmaceutical University, 2011, 42(6): 527-533.
    [4]Determination of Cyclosporin A in Ocular Tissues by HPLC-MS[J]. Journal of China Pharmaceutical University, 2003, (4): 44-47.
    [5]Content Determination and Stability Research on Diclofenac-Zn[J]. Journal of China Pharmaceutical University, 2002, (3): 92-93.
    [6]Determination of Contents of Dextromethorphan Hydrobromide and Guaifenesine in Capsules by HPLC[J]. Journal of China Pharmaceutical University, 1999, (5): 367-369.
    [7]Determination of Norgestrel in Compound Preparation by First Derivative Spectrography[J]. Journal of China Pharmaceutical University, 1995, (4): 246-247.
    [8]HPLC Determination of Diclofenac in Transdermal Receiver Solution[J]. Journal of China Pharmaceutical University, 1994, (6): 342-344.
    [9]A Reversed-Phase HPLC Method for the Determination of Paeoniflorin Content[J]. Journal of China Pharmaceutical University, 1994, (4): 46-48.
    [10]Study on the Content of Tetrahydropalmatine in Corydalis Yanhusuo by SLS-micellar Enhanced Fluorometry[J]. Journal of China Pharmaceutical University, 1993, (6): 345-347.

Catalog

    Article views (264) PDF downloads (616) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return